Pre-Symptomatic Transmission Is Very Real

COVID19 - CORONAVIRUS, 14 Jun 2021

Swiss Policy Research - TRANSCEND Media Service

Fact or fiction? Pre-symptomatic transmission of the coronavirus (MIT Medical, May 2020)

12 Jun 2021 – Pre-symptomatic transmission is real. But face masks still don’t work.

Because many authorities justified mask mandates with pre-symptomatic or asymptomatic coronavirus transmission, many skeptics and critics tried to argue against the existence or importance of pre-symptomatic and asymptomatic transmission. But pre- and asymptomatic transmission is real for the same reason that face masks don’t work: aerosols.

In fact, numerous studies have shown that Sars-CoV-2 respiratory viral load peaks shortly before or shortly after symptom onset (see diagrams below). Once symptoms become apparent, it means the immune system has kicked in and viral load decreases rapidly.

The idea that only symptomatic people spread viral particles, by sneezing or coughing, is based on the obsolete ‘droplet model’ of virus transmission. In reality, transmission occurs primarily, and perhaps almost exclusively, via inhaled aerosols produced when breathing, talking, singing, coughing, or whatever. Droplets, by definition, cannot be inhaled.

Skeptics often point to a famous Wuhan study, published in November 2020 in Nature Communications, that allegedly showed that asymptomatic transmission is a myth, as even a commentary in the BMJ argued. In reality, the Wuhan study was a post-lockdown PCR study which tested 10 million Wuhan citizens in late May 2020 and found 300 who still had a positive PCR test.

But as the study notes, none of these people had positive virus cultures. Thus, these 300 cases were classic post-infectious high-CT PCR positives, who obviously couldn’t infect anyone anymore. In other words, the famous Wuhan study said nothing at all about pre- and asymptomtic transmission.

(Another common misunderstanding about Wuhan is the idea that the city turned into a major coronavirus hotspot. In reality, antibody seroprevalence in Wuhan was only about 1% to 5% by May 2020. At the same time, New York City had already a seroprevalence of at least 20%.)

Pre-symptomatic transmission is already well known from influenza, and it would have been truly surprising if it had played no role at all in the case of the new coronavirus. Indeed, it looks like pre-symptomatic transmission is even more important in the case of the new coronavirus, with estimates ranging between 30% and 60% of all virus transmission.

Pre-symptomatic or “stealth” transmission is also a major reason why Sars-Cov-2 could spread so rapidly and create a global pandemic. The real ‘myth’, or rather exception, might be sick people coughing straight into the faces of healthy people.

In contrast to transmission by pre-symptomatic people (i.e. a few days or hours before symptom onset), transmission by people who remain fully asymptomatic is a bit more complex to evaluate, because this group includes some people with a low viral load, which makes them less contagious. In addition, fully asymptomatic people are much more difficult to detect. However, nobody knows beforehand if they will develop symptoms or not, and as a Swedish doctor recently showed, even fully asymptomatic transmission has been documented in several carefully designed studies.

In conclusion, pre-symptomatic aerosol transmission is very real and has played an important role in driving the coronavirus pandemic. For the very same reason, face masks, ‘temperature screening’, reactive lockdowns, and even ‘contact tracing’ (beyond the very early phase) have not worked.

Scientific diagrams

A) Viral load and culture probability over time

Rapidly decreasing viral load and (especially) infectiousness.

Viral load and estimated infectious virus shedding time series (Jones et al, May 2021)

B) Symptom onset compared to peak viral load

Mean delay between peak viral load and self-reported symptom onset is 4 days.

Patient-reported onset of symptoms compared to estimated day of peak viral load (Jones et al, May 2021, Figure S15)

C) Temporal pattern of viral shedding

Rapidly decreasing viral load (PCR ct value) after symptom onset.

Temporal patterns of viral shedding (He et al, April 2020)

D) SARS-1, SARS-2, MERS: Viral load vs. symptom onset

SARS-2: Peak viral load near symptom onset – easy transmission. SARS-1 and MERS: Viral load increases only after symptom onset – poor transmission.

SARS-1, SARS-2, MERS: Respiratory viral load by day of symptom onset (Benefield, September 2020)

E) Aerosols: Respiratory pathogen transmission routes (2018)

Aerosols as the primary mode of transmission, even at close range.

Respiratory pathogen transmission routes (Ian Mackay, 2018)

See also


Swiss Policy Research, founded in 2016, is an independent, nonpartisan and nonprofit research group investigating geopolitical propaganda in Swiss and international media. SPR is composed of independent academics that for personal and professional reasons prefer to protect their identities, and receives no external funding; there are no financial sponsors or backers. Our articles have been published or shared by numerous independent media outlets and journalists, among them Julian Assange, and have been translated into more than two dozen languages.

Go to Original –

Tags: , , , , , , , , , , , , , , , , , , ,


Share this article:

DISCLAIMER: The statements, views and opinions expressed in pieces republished here are solely those of the authors and do not necessarily represent those of TMS. In accordance with title 17 U.S.C. section 107, this material is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. TMS has no affiliation whatsoever with the originator of this article nor is TMS endorsed or sponsored by the originator. “GO TO ORIGINAL” links are provided as a convenience to our readers and allow for verification of authenticity. However, as originating pages are often updated by their originating host sites, the versions posted may not match the versions our readers view when clicking the “GO TO ORIGINAL” links. This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: If you wish to use copyrighted material from this site for purposes of your own that go beyond ‘fair use’, you must obtain permission from the copyright owner.

Comments are closed.